COPT Defense Properties is the only public REIT with the security clearances and SCIF expertise required for top-secret ...
Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, announced that the U.S. Food ...
Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one ...
Companies like Kairos Power are building new types of reactors with the encouragement of the Trump administration, but their ...
A simple, speedy single-slope ADC with a biphasic conversion cycle and a decent accuracy. Read on to learn more!
Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical evaluationCompelling anti-inflammatory activity of G1090N was ...
MarketBeat on MSN
Redwire is quietly winning the space economy's next phase
The global space economy is undergoing a fundamental shift. For the past decade, the narrative has been dominated by ...
For retirement savers and retirees, the new year brings more than the usual inflation adjustments to retirement contributions ...
Recent leaks surrounding Grok 5 point to an AI model so vast that it may disrupt the current information hierarchy. This ...
Tamil Nadu politics had settled into a fragile equilibrium after the AIADMK’s 2017 split, until actor Vijay announced his ...
Nivedita Menon reflects on JNU’s transformation since 2016, the ideological capture of faculty and curricula, and how the ...
As it turns out, not everyone has a loan on their house. In fact, 40 percent of U.S. homes don’t have a mortgage, per the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results